Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_assertion type Assertion NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_head.
- NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_assertion description "[The SDF-1 homozygous 3'A variant was related to more-rapid disease progression, and CCR5 Delta32 was associated with reduced rates of hazard for disease progression in nucleoside-treated subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_provenance.
- NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_assertion evidence source_evidence_literature NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_provenance.
- NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_assertion SIO_000772 11709782 NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_provenance.
- NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_assertion wasDerivedFrom gad-20150221 NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_provenance.
- NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_assertion wasGeneratedBy ECO_0000203 NP57167.RA_YJCNRPRGE4NhExyJrRytUU4gH6VLQKYM63M3duFx0o130_provenance.